Fundamentals screen · refreshed after the Sep 28, 2026 close
Highest profit margins: Healthcare
Large companies keeping the most of each dollar of revenue as profit. Net margin for the latest quarter: net income divided by revenue.
| # | Company | Price | Net margin | Gross margin | Revenue YoY | Mkt cap |
|---|---|---|---|---|---|---|
| 1 | CDNACareDxHealthcare | $64.60 | 83.8% | 73.5% | +52.2% | $3.34B |
| 2 | PTGXProtagonist TherapeuticsHealthcare | $142.44 | 76.3% | 100.0% | +3749.2% | $9.22B |
| 3 | LGNDLigand PharmaceuticalsHealthcare | $314.10 | 76.2% | 82.2% | +33.7% | $6.26B |
| 4 | BIO.BBio-Rad LaboratoriesHealthcare | $268.89 | 57.1% | 53.1% | −0.1% | $7.19B |
| 5 | BIOBio-Rad LaboratoriesHealthcare | $377.69 | 57.1% | 53.1% | −0.1% | $10.10B |
| 6 | MGTXMeiraGTx HoldingsHealthcare | $11.11 | 50.0% | 97.8% | +8608.6% | $1.07B |
| 7 | HALOHalozyme TherapeuticsHealthcare | $112.89 | 47.8% | 83.5% | +47.7% | $12.81B |
| 8 | OMEROmerosHealthcare | $19.43 | 46.4% | 97.2% | — | $1.41B |
| 9 | KRYSKrystal BiotechHealthcare | $337.08 | 45.9% | 94.6% | +24.1% | $9.98B |
| 10 | CRONCronos Group Inc. Common ShareHealthcare | $3.41 | 45.4% | 65.8% | +59.5% | $1.26B |
| 11 | AUPHAurinia PharmaceuticalsHealthcare | $16.52 | 45.0% | 92.1% | +18.9% | $2.20B |
| 12 | LQDALiquidiaHealthcare | $73.67 | 43.5% | 93.3% | +1842.7% | $6.59B |
| 13 | UTHRUnited TherapeuticsHealthcare | $485.54 | 42.5% | 87.3% | −1.9% | $20.83B |
| 14 | COOThe Cooper CompaniesHealthcare | $56.57 | 40.6% | 66.8% | +0.6% | $10.76B |
| 15 | KLACKLAHealthcare | $189.17 | 37.3% | 61.4% | +15.2% | $246.87B |
| 16 | PGENPrecigenHealthcare | $7.81 | 36.5% | 94.9% | +6322.7% | $2.80B |
| 17 | BCRXBioCryst PharmaceuticalsHealthcare | $8.47 | 35.9% | 98.2% | +33.6% | $2.16B |
| 18 | INDVIndivior PharmaceuticalsHealthcare | $36.88 | 35.6% | 85.4% | +13.6% | $4.35B |
| 19 | EXELExelixisHealthcare | $58.37 | 33.7% | 96.7% | +10.6% | $14.46B |
| 20 | VIRVir BiotechnologyHealthcare | $10.51 | 33.5% | 100.0% | +19582.5% | $1.78B |
| 21 | VRTXVertex PharmaceuticalsHealthcare | $527.67 | 33.0% | 85.3% | +12.5% | $133.74B |
| 22 | LLYEli Lilly &Healthcare | $1,184.78 | 30.9% | 85.8% | +47.7% | $1.06T |
| 23 | ETONEton PharmaceutcialsHealthcare | $59.18 | 30.8% | 67.6% | +98.6% | $1.69B |
| 24 | ADMAADMA BiologicsHealthcare | $10.12 | 30.4% | 69.4% | +2.0% | $2.27B |
| 25 | REGNRegeneron PharmaceuticalsHealthcare | $752.25 | 30.2% | 86.6% | +16.7% | $77.45B |
| 26 | HRMYHarmony Biosciences HoldingsHealthcare | $40.01 | 28.9% | 75.8% | +30.3% | $2.33B |
| 27 | ISRGIntuitive SurgicalHealthcare | $414.79 | 28.3% | 67.8% | +18.5% | $146.54B |
| 28 | ZTSZOETISHealthcare | $71.43 | 28.0% | 72.7% | −0.2% | $29.52B |
| 29 | IDXXIdexx LaboratoriesHealthcare | $529.06 | 27.8% | 64.0% | +9.7% | $41.68B |
| 30 | LIVNLivaNovaHealthcare | $77.21 | 27.8% | 70.1% | +10.8% | $4.25B |
| 31 | RMDResMedHealthcare | $222.10 | 26.2% | 59.4% | +8.6% | $32.04B |
| 32 | BMYBristol-Myers SquibbHealthcare | $63.88 | 25.6% | 71.3% | +5.7% | $130.49B |
| 33 | IRMDiRadimedHealthcare | $86.66 | 25.5% | 74.1% | +0.3% | $1.11B |
Method & sources
Computed after each close from Massive / Polygon prices (split-adjusted), SEC filings, FINRA short-interest settlements and FMP earnings dates. Rows are rebuilt every session; a stock appears only when every criterion is met with current data. Full methodology
Informational screen, not a recommendation.